Share Price and Basic Stock Data
Last Updated: January 9, 2026, 4:00 am
| PEG Ratio | 0.36 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sicagen India Ltd operates in the Trading & Distributors industry, with a current market capitalization of ₹231 Cr and a share price of ₹58.5. The company has shown fluctuations in revenue over recent quarters, with total sales reported at ₹895 Cr for the fiscal year ending March 2023, slightly declining to ₹795 Cr for March 2024. The trailing twelve months (TTM) sales stood at ₹893 Cr, indicating a stable revenue stream despite the dip in the annual figures. Quarterly sales peaked at ₹258.19 Cr in December 2022 but have since varied, with the latest quarter (September 2023) recording ₹180.08 Cr. This suggests a potential seasonal impact or market challenges affecting sales performance. The overall trend reflects a need for strategic adjustments to regain growth momentum, as revenues must align with operational capabilities and market demands.
Profitability and Efficiency Metrics
The profitability of Sicagen India Ltd, as indicated by the operating profit margin (OPM), stood at 4.00% for the latest fiscal year, showing a gradual improvement from previous periods. The operating profit reached ₹36 Cr for March 2025, up from ₹27 Cr in March 2023, reflecting enhanced operational efficiency. However, the return on equity (ROE) at 3.41% and return on capital employed (ROCE) at 5.57% remain relatively low compared to industry standards, which typically range higher, indicating potential underutilization of capital. The interest coverage ratio (ICR) is robust at 3.95x, allowing the firm to comfortably meet its debt obligations. Nevertheless, the cash conversion cycle of 134 days indicates a slower turnaround in cash flows, suggesting room for improvement in managing receivables and inventory.
Balance Sheet Strength and Financial Ratios
Sicagen’s balance sheet reveals total assets of ₹722 Cr, with liabilities amounting to ₹90 Cr in other liabilities and ₹164 Cr in borrowings. The company’s reserves have increased to ₹478 Cr, illustrating a strengthening equity position, although it also reflects a high leverage ratio of 0.27, which can be a concern if economic conditions worsen. The price-to-book value ratio stands at 0.50x, indicating that the market may undervalue the company’s net assets compared to its equity. Current and quick ratios are healthy at 2.29x and 1.70x respectively, showcasing the company’s ability to cover short-term liabilities. The working capital days have improved to 88 days, reflecting better liquidity management, although the cash conversion cycle suggests there is still a significant lag in converting sales into cash.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sicagen India Ltd indicates a strong promoter holding at 61.13%, providing stability and commitment to the company’s long-term vision. However, foreign institutional investors (FIIs) have reduced their stake to 2.42%, down from a high of 7.34% in previous periods, which may indicate waning confidence among international investors. Domestic institutional investors (DIIs) hold a marginal 0.58%, while the public holds 35.88% of the shares, reflecting a balanced distribution of ownership. The total number of shareholders has decreased to 23,326, suggesting potential concerns regarding investor sentiment. The decline in public and institutional interest might impact liquidity and stock performance, warranting closer examination of management strategies to enhance investor relations and market perception.
Outlook, Risks, and Final Insight
The outlook for Sicagen India Ltd hinges on its ability to stabilize revenues and enhance profitability metrics amidst market volatility. Key strengths include a solid promoter backing and a manageable interest coverage ratio, which can support operational flexibility. However, risks persist, particularly due to low ROE and ROCE figures, indicating inefficiencies. Additionally, the declining trend in FIIs and overall shareholder numbers raises concerns about market confidence. To mitigate these risks, Sicagen must focus on improving operational efficiencies, optimizing working capital, and enhancing investor communication. If the company can successfully navigate these challenges, it may reposition itself for growth; conversely, failure to address these issues could lead to further declines in shareholder value and market perception.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 58.9 Cr. | 3.07 | 5.59/2.85 | 39.3 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 12.5 Cr. | 14.2 | 17.9/13.0 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 6.19 Cr. | 68.0 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 150 Cr. | 47.8 | 54.5/10.2 | 166 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 105 Cr. | 94.3 | 174/84.4 | 14.8 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 9,461.53 Cr | 158.55 | 86.76 | 122.20 | 0.41% | 15.37% | 8.86% | 7.71 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 245.82 | 258.19 | 227.42 | 166.43 | 180.08 | 227.70 | 221.23 | 232.26 | 197.71 | 210.26 | 251.65 | 204.54 | 226.76 |
| Expenses | 242.46 | 251.32 | 216.05 | 157.99 | 174.97 | 222.48 | 212.85 | 222.99 | 189.44 | 203.04 | 240.91 | 194.80 | 217.70 |
| Operating Profit | 3.36 | 6.87 | 11.37 | 8.44 | 5.11 | 5.22 | 8.38 | 9.27 | 8.27 | 7.22 | 10.74 | 9.74 | 9.06 |
| OPM % | 1.37% | 2.66% | 5.00% | 5.07% | 2.84% | 2.29% | 3.79% | 3.99% | 4.18% | 3.43% | 4.27% | 4.76% | 4.00% |
| Other Income | 2.95 | 1.87 | 7.55 | 1.32 | 1.49 | 2.85 | 1.44 | 2.03 | 2.72 | 3.18 | 2.27 | 1.92 | 1.75 |
| Interest | 2.05 | 2.28 | 2.64 | 2.59 | 2.47 | 2.65 | 2.94 | 2.62 | 2.83 | 2.50 | 3.07 | 3.04 | 2.71 |
| Depreciation | 2.78 | 2.13 | 3.55 | 2.12 | 2.12 | 2.19 | 3.33 | 2.29 | 2.31 | 2.39 | 3.51 | 2.39 | 2.37 |
| Profit before tax | 1.48 | 4.33 | 12.73 | 5.05 | 2.01 | 3.23 | 3.55 | 6.39 | 5.85 | 5.51 | 6.43 | 6.23 | 5.73 |
| Tax % | 37.16% | 20.32% | 12.25% | 24.75% | 35.32% | 28.17% | 12.68% | 24.88% | 29.23% | 23.77% | 38.26% | 27.13% | 27.75% |
| Net Profit | 0.93 | 3.45 | 11.17 | 3.80 | 1.30 | 2.32 | 3.10 | 4.80 | 4.14 | 4.20 | 3.97 | 4.54 | 4.14 |
| EPS in Rs | 0.24 | 0.87 | 2.82 | 0.96 | 0.33 | 0.59 | 0.78 | 1.21 | 1.05 | 1.06 | 1.00 | 1.15 | 1.05 |
Last Updated: December 29, 2025, 3:58 am
Below is a detailed analysis of the quarterly data for Sicagen India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 226.76 Cr.. The value appears strong and on an upward trend. It has increased from 204.54 Cr. (Jun 2025) to 226.76 Cr., marking an increase of 22.22 Cr..
- For Expenses, as of Sep 2025, the value is 217.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 194.80 Cr. (Jun 2025) to 217.70 Cr., marking an increase of 22.90 Cr..
- For Operating Profit, as of Sep 2025, the value is 9.06 Cr.. The value appears to be declining and may need further review. It has decreased from 9.74 Cr. (Jun 2025) to 9.06 Cr., marking a decrease of 0.68 Cr..
- For OPM %, as of Sep 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 4.76% (Jun 2025) to 4.00%, marking a decrease of 0.76%.
- For Other Income, as of Sep 2025, the value is 1.75 Cr.. The value appears to be declining and may need further review. It has decreased from 1.92 Cr. (Jun 2025) to 1.75 Cr., marking a decrease of 0.17 Cr..
- For Interest, as of Sep 2025, the value is 2.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.04 Cr. (Jun 2025) to 2.71 Cr., marking a decrease of 0.33 Cr..
- For Depreciation, as of Sep 2025, the value is 2.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.39 Cr. (Jun 2025) to 2.37 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 5.73 Cr.. The value appears to be declining and may need further review. It has decreased from 6.23 Cr. (Jun 2025) to 5.73 Cr., marking a decrease of 0.50 Cr..
- For Tax %, as of Sep 2025, the value is 27.75%. The value appears to be increasing, which may not be favorable. It has increased from 27.13% (Jun 2025) to 27.75%, marking an increase of 0.62%.
- For Net Profit, as of Sep 2025, the value is 4.14 Cr.. The value appears to be declining and may need further review. It has decreased from 4.54 Cr. (Jun 2025) to 4.14 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.05. The value appears to be declining and may need further review. It has decreased from 1.15 (Jun 2025) to 1.05, marking a decrease of 0.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 620 | 645 | 601 | 711 | 738 | 820 | 699 | 542 | 836 | 895 | 795 | 892 | 893 |
| Expenses | 631 | 644 | 608 | 707 | 737 | 817 | 688 | 533 | 814 | 869 | 768 | 856 | 856 |
| Operating Profit | -11 | 1 | -7 | 3 | 1 | 3 | 11 | 9 | 22 | 27 | 28 | 36 | 37 |
| OPM % | -2% | 0% | -1% | 0% | 0% | 0% | 2% | 2% | 3% | 3% | 3% | 4% | 4% |
| Other Income | 41 | 18 | 18 | 15 | 15 | 15 | 11 | 8 | -0 | 15 | 7 | 9 | 9 |
| Interest | 7 | 6 | 6 | 7 | 9 | 9 | 9 | 5 | 6 | 9 | 11 | 11 | 11 |
| Depreciation | 6 | 5 | 5 | 4 | 5 | 6 | 10 | 10 | 11 | 11 | 10 | 10 | 11 |
| Profit before tax | 17 | 8 | -1 | 8 | 2 | 3 | 3 | 1 | 5 | 22 | 14 | 24 | 24 |
| Tax % | 1% | 13% | -300% | 3% | 30% | 95% | 89% | 322% | 112% | 18% | 24% | 29% | |
| Net Profit | 17 | 7 | 1 | 7 | 1 | 0 | 0 | -3 | -1 | 18 | 11 | 17 | 17 |
| EPS in Rs | 4.27 | 1.67 | 0.27 | 1.89 | 0.29 | 0.03 | 0.09 | -0.81 | -0.15 | 4.50 | 2.66 | 4.32 | 4.26 |
| Dividend Payout % | 19% | 36% | 224% | 32% | 206% | 1,218% | 550% | -74% | -162% | 13% | 23% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -58.82% | -85.71% | 600.00% | -85.71% | -100.00% | 66.67% | 1900.00% | -38.89% | 54.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.89% | 685.71% | -685.71% | -14.29% | 166.67% | 1833.33% | -1938.89% | 93.43% |
Sicagen India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 113% |
| 3 Years: | 136% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 45% |
| 3 Years: | 27% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:31 pm
Balance Sheet
Last Updated: January 7, 2026, 4:24 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
| Reserves | 441 | 439 | 443 | 345 | 353 | 343 | 336 | 355 | 383 | 400 | 420 | 444 | 478 |
| Borrowings | 73 | 48 | 60 | 89 | 97 | 119 | 96 | 79 | 95 | 121 | 121 | 148 | 164 |
| Other Liabilities | 119 | 84 | 76 | 105 | 114 | 184 | 133 | 72 | 140 | 68 | 143 | 90 | 148 |
| Total Liabilities | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
| Fixed Assets | 64 | 59 | 57 | 183 | 203 | 151 | 168 | 168 | 141 | 141 | 140 | 137 | 140 |
| CWIP | 0 | 1 | 2 | 12 | 0 | 0 | 1 | 0 | -0 | 0 | 1 | -0 | 1 |
| Investments | 100 | 100 | 100 | 54 | 34 | 26 | 20 | 37 | 70 | 69 | 73 | 79 | 93 |
| Other Assets | 509 | 451 | 460 | 329 | 367 | 507 | 417 | 340 | 445 | 418 | 510 | 505 | 596 |
| Total Assets | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
Below is a detailed analysis of the balance sheet data for Sicagen India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 40.00 Cr..
- For Reserves, as of Sep 2025, the value is 478.00 Cr.. The value appears strong and on an upward trend. It has increased from 444.00 Cr. (Mar 2025) to 478.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 164.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 148.00 Cr. (Mar 2025) to 164.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Mar 2025) to 148.00 Cr., marking an increase of 58.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 596.00 Cr.. The value appears strong and on an upward trend. It has increased from 505.00 Cr. (Mar 2025) to 596.00 Cr., marking an increase of 91.00 Cr..
- For Total Assets, as of Sep 2025, the value is 830.00 Cr.. The value appears strong and on an upward trend. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (478.00 Cr.) exceed the Borrowings (164.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -84.00 | -47.00 | -67.00 | -86.00 | -96.00 | -116.00 | -85.00 | -70.00 | -73.00 | -94.00 | -93.00 | -112.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 61 | 71 | 75 | 91 | 119 | 108 | 115 | 107 | 76 | 114 | 94 |
| Inventory Days | 70 | 56 | 59 | 70 | 68 | 58 | 78 | 80 | 50 | 65 | 67 | 60 |
| Days Payable | 35 | 19 | 19 | 32 | 42 | 75 | 60 | 40 | 60 | 24 | 47 | 20 |
| Cash Conversion Cycle | 110 | 98 | 110 | 113 | 117 | 102 | 126 | 155 | 97 | 117 | 134 | 134 |
| Working Capital Days | 67 | 69 | 78 | 67 | 73 | 61 | 99 | 114 | 84 | 85 | 97 | 88 |
| ROCE % | 2% | 2% | 1% | 3% | 2% | 3% | 3% | 2% | 4% | 4% | 4% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Diluted EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Cash EPS (Rs.) | 6.98 | 5.12 | 7.17 | 2.61 | 1.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Revenue From Operations / Share (Rs.) | 225.39 | 201.02 | 226.26 | 211.31 | 136.88 |
| PBDIT / Share (Rs.) | 11.01 | 8.66 | 8.77 | 7.72 | 4.25 |
| PBIT / Share (Rs.) | 8.35 | 6.19 | 6.11 | 4.96 | 1.74 |
| PBT / Share (Rs.) | 6.11 | 3.50 | 5.47 | 1.27 | 0.36 |
| Net Profit / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| NP After MI And SOA / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| PBDIT Margin (%) | 4.88 | 4.30 | 3.87 | 3.65 | 3.10 |
| PBIT Margin (%) | 3.70 | 3.07 | 2.69 | 2.34 | 1.27 |
| PBT Margin (%) | 2.71 | 1.73 | 2.41 | 0.59 | 0.26 |
| Net Profit Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| NP After MI And SOA Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| Return on Networth / Equity (%) | 3.53 | 2.28 | 4.05 | -0.14 | -0.81 |
| Return on Capital Employeed (%) | 6.58 | 5.12 | 5.29 | 4.47 | 1.60 |
| Return On Assets (%) | 2.37 | 1.50 | 2.83 | -0.09 | -0.56 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.27 | 0.22 | 0.24 | 0.18 | 0.16 |
| Asset Turnover Ratio (%) | 1.26 | 1.20 | 1.39 | 0.85 | 0.66 |
| Current Ratio (X) | 2.29 | 2.17 | 2.38 | 2.01 | 2.57 |
| Quick Ratio (X) | 1.70 | 1.58 | 1.55 | 1.54 | 1.76 |
| Inventory Turnover Ratio (X) | 6.85 | 2.28 | 3.78 | 0.70 | 0.48 |
| Dividend Payout Ratio (NP) (%) | 13.85 | 22.59 | 5.55 | -388.52 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.58 | 11.69 | 3.49 | 22.96 | 0.00 |
| Earning Retention Ratio (%) | 86.15 | 77.41 | 94.45 | 488.52 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.42 | 88.31 | 96.51 | 77.04 | 0.00 |
| Interest Coverage Ratio (X) | 3.95 | 3.22 | 3.91 | 5.18 | 3.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.36 | 1.98 | 2.29 | 2.37 | 0.41 |
| Enterprise Value (Cr.) | 307.23 | 291.78 | 198.21 | 139.51 | 85.90 |
| EV / Net Operating Revenue (X) | 0.34 | 0.36 | 0.22 | 0.16 | 0.15 |
| EV / EBITDA (X) | 7.05 | 8.52 | 5.71 | 4.57 | 5.10 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| Retention Ratios (%) | 86.14 | 77.40 | 94.44 | 488.52 | 0.00 |
| Price / BV (X) | 0.50 | 0.50 | 0.27 | 0.20 | 0.14 |
| Price / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| EarningsYield | 0.07 | 0.04 | 0.14 | -0.01 | -0.05 |
After reviewing the key financial ratios for Sicagen India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 5.12 (Mar 24) to 6.98, marking an increase of 1.86.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 225.39. It has increased from 201.02 (Mar 24) to 225.39, marking an increase of 24.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.01. This value is within the healthy range. It has increased from 8.66 (Mar 24) to 11.01, marking an increase of 2.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 8.35, marking an increase of 2.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 3.50 (Mar 24) to 6.11, marking an increase of 2.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has increased from 4.30 (Mar 24) to 4.88, marking an increase of 0.58.
- For PBIT Margin (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 10. It has increased from 3.07 (Mar 24) to 3.70, marking an increase of 0.63.
- For PBT Margin (%), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 10. It has increased from 1.73 (Mar 24) to 2.71, marking an increase of 0.98.
- For Net Profit Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 5. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 8. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 15. It has increased from 2.28 (Mar 24) to 3.53, marking an increase of 1.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.58. This value is below the healthy minimum of 10. It has increased from 5.12 (Mar 24) to 6.58, marking an increase of 1.46.
- For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 24) to 2.37, marking an increase of 0.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.27, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.26. It has increased from 1.20 (Mar 24) to 1.26, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.29, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.85. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 6.85, marking an increase of 4.57.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.85. This value is below the healthy minimum of 20. It has decreased from 22.59 (Mar 24) to 13.85, marking a decrease of 8.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 20. It has decreased from 11.69 (Mar 24) to 8.58, marking a decrease of 3.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 86.15. This value exceeds the healthy maximum of 70. It has increased from 77.41 (Mar 24) to 86.15, marking an increase of 8.74.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.42. This value exceeds the healthy maximum of 70. It has increased from 88.31 (Mar 24) to 91.42, marking an increase of 3.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.95. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 3.95, marking an increase of 0.73.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 1.98 (Mar 24) to 2.36, marking an increase of 0.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 307.23. It has increased from 291.78 (Mar 24) to 307.23, marking an increase of 15.45.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.34, marking a decrease of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.05, marking a decrease of 1.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 86.14. This value exceeds the healthy maximum of 70. It has increased from 77.40 (Mar 24) to 86.14, marking an increase of 8.74.
- For Price / BV (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.07, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sicagen India Ltd:
- Net Profit Margin: 1.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.58% (Industry Average ROCE: 15.37%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.53% (Industry Average ROE: 8.86%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.7
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.4 (Industry average Stock P/E: 86.76)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 4th Floor, SPIC House, No.88, Mount Road, Chennai (Madras) Tamil Nadu 600032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashwin C Muthiah | Chairman |
| Mr. Nandakumar Varma | Whole Time Director |
| Mr. R Chandrasekar | Director |
| Mr. Devaki Ashwin Muthiah | Director |
| Ms. Govindarajan Dattatreyan Sharma | Independent Director |
| Ms. Rita Chandrasekar | Independent Director |
| Mr. S Radhakrishnan | Independent Director |
| Mr. Batchu Sai Purshotham | Independent Director |
FAQ
What is the intrinsic value of Sicagen India Ltd?
Sicagen India Ltd's intrinsic value (as of 09 January 2026) is ₹52.39 which is 5.60% lower the current market price of ₹55.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹220 Cr. market cap, FY2025-2026 high/low of ₹83.5/53.0, reserves of ₹478 Cr, and liabilities of ₹830 Cr.
What is the Market Cap of Sicagen India Ltd?
The Market Cap of Sicagen India Ltd is 220 Cr..
What is the current Stock Price of Sicagen India Ltd as on 09 January 2026?
The current stock price of Sicagen India Ltd as on 09 January 2026 is ₹55.5.
What is the High / Low of Sicagen India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sicagen India Ltd stocks is ₹83.5/53.0.
What is the Stock P/E of Sicagen India Ltd?
The Stock P/E of Sicagen India Ltd is 14.4.
What is the Book Value of Sicagen India Ltd?
The Book Value of Sicagen India Ltd is 131.
What is the Dividend Yield of Sicagen India Ltd?
The Dividend Yield of Sicagen India Ltd is 1.80 %.
What is the ROCE of Sicagen India Ltd?
The ROCE of Sicagen India Ltd is 5.57 %.
What is the ROE of Sicagen India Ltd?
The ROE of Sicagen India Ltd is 3.41 %.
What is the Face Value of Sicagen India Ltd?
The Face Value of Sicagen India Ltd is 10.0.